Coenzyme q10 liquid supplementation in dyslipidemic subjects with statin-related clinical symptoms: a double-blind, randomized, placebo-controlled study
Giuseppe Derosa,1–3 Angela D’Angelo,2 Pamela Maffioli1 1Center of Diabetes and Metabolic Diseases, Department of Internal Medicine and Therapeutics, University of Pavia and Fondazione IRCCS Policlinico San Matteo, Pavia, Italy; 2Laboratory of Molecular Medicine, University of Pav...
Saved in:
Main Authors: | Derosa G (Author), D'Angelo A (Author), Maffioli P (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2019-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Coenzyme Q10 Supplementation in Statin Treated Patients: A Double-Blinded Randomized Placebo-Controlled Trial
by: Tine L. Dohlmann, et al.
Published: (2022) -
Effect of a food supplement containing berberine, monacolin K, hydroxytyrosol and coenzyme Q10 on lipid levels: a randomized, double-blind, placebo controlled study
by: D'Addato S, et al.
Published: (2017) -
A randomized, double-blind clinical trial of canrenone vs hydrochlorothiazide in addition to angiotensin II receptor blockers in hypertensive type 2 diabetic patients
by: Derosa G, et al.
Published: (2018) -
Biosynthesis, Deficiency, and Supplementation of Coenzyme Q
by: Carmine Staiano, et al.
Published: (2023) -
The Effect of Coenzyme Q10 Supplementation on Vascular Endothelial Growth Factor and Serum Levels of Interleukin 6 and 8 in Women with Breast Cancer: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial
by: Zahrooni N, et al.
Published: (2019)